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ABSTRACT
Introduction Survivors of muscle invasive bladder cancer 
(MIBC) experience physical and psychosocial side effects 
of cancer diagnosis and treatment. These negative side 
effects have a crucial impact on their health-related 
quality of life (HRQoL). To date, there is evidence that 
rehabilitation interventions such as physical activity and 
psychosocial support have a positive effect on the HRQoL 
of cancer survivors. Unfortunately, there are no specific 
guidelines for rehabilitation or survivorship programmes 
for MIBC survivors. Therefore, this systematic review aims 
to assess the effects of exercise-based and psychosocial 
rehabilitation interventions in MIBC survivors.
Methods and analysis The approach of this review is 
consistent with the Cochrane methodology. Randomized 
controlled trials and non-randomised studies will be 
included. The population of interest is patients (≥18 years 
of age) with diagnosis of MIBC or high-risk non-MIBC for 
whom a radical cystectomy is indicated. There will be two 
eligible intervention types for inclusion: exercise-based 
and psychosocial rehabilitation interventions. The primary 
outcome measures are patient-reported outcomes (eg, 
HRQoL, fatigue and pain) and physical fitness. Studies 
will be identified independently by two review authors 
by searching the Cochrane Central Register of Controlled 
Trials, MEDLINE, Embase, Web of Science and the 
Physiotherapy Evidence Database. A third reviewer will 
be asked by disagreements. Risk of bias will be assessed 
using the Cochrane Collaboration tool and the Newcastle-
Ottawa Scale. Data will be summarised descriptively. If 
homogeneity of the studies is sufficient, meta-analysis 
will be undertaken. The broad scope of this review (ie, 
different interventions and study designs) is needed to 
have a comprehensive view on effective rehabilitation 
interventions.
Ethics and dissemination Ethics approval is not 
required, as no primary data will be collected. Results will 
be disseminated through a peer-reviewed publication.
Background
description of the condition
Bladder cancer (BC) is the 11th most 
common cancer worldwide. When both 
genders are considered separately, BC in 
men is rising to the seventh place, while BC 
in women is dropping to the 17th place of 
most common cancer worldwide.1 2 Since BC 
is mainly diagnosed at more advanced age, 
the incidence is expected to raise due to an 
increased life expectancy.3 4 Thirty per cent 
of the BC patients are diagnosed with muscle 
invasive BC (MIBC, stages T2-T4)5 and up to 
45% of patients with non-MIBC (NMIBC) 
will eventually progress to MIBC.6 The stan-
dard treatment of MIBC is neo-adjuvant 
chemotherapy followed by radical cystectomy 
combined with an extended pelvic lymph 
node dissection and urinary diversion (conti-
nent or incontinent bladder replacement). 
Also patients with high-risk NMIBC can be 
offered a radical cystectomy.1 This aggressive 
approach is associated with a variety of nega-
tive side effects, mainly hampering urinary, 
gastrointestinal and sexual function. This can 
lead to a loss of health-related quality of life 
(HRQoL), which refers to the patients’ own 
perceptions of their health and ability to func-
tion7 encompassing physical, psychological, 
social and spiritual dimensions.8 Bladder-pre-
serving radiochemotherapy is an alternative 
for radical cystectomy. Both radiotherapy 
and chemotherapy can also be used in the 
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Strengths and limitations of this study
 ► The overall approach of this review is consistent 
with the methodology described in the Cochrane 
Handbook for Systematic Reviews of Interventions.
 ► It is an innovative topic in the field of bladder cancer.
 ► Actual problem because the incidence of bladder 
cancer is rising.
 ► Possible paucity of studies meeting the inclusion 
criteria.
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adjuvant or palliative setting and can cause important 
treatment-related side effects. Therefore, follow-up care 
beyond the acute diagnosis and treatment phase is neces-
sary.9
description of the intervention
The World Health Organization (WHO) has 
defined rehabilitation as ‘the use of all means 
aimed at reducing the impact of disabling and 
handicapping conditions at enabling people with 
disabilities to achieve optimal social integration’.10 A 
more specific definition of rehabilitation in the setting of 
cancer is the following: ‘cancer rehabilitation is a concept 
that is defined by the patient and involves helping a 
person with cancer to obtain maximum physical, social, 
psychological, and vocational functioning within the limit 
by the disease and its treatment’.11 Therefore, cancer 
rehabilitation needs to comprise different intervention 
approaches.12 13
Physical activity (PA) is seen as one of the rehabilitation 
interventions to improve patient’s quality of life (QOL) 
and survival outcomes. PA is defined as ‘any movement 
created by the skeletal muscles that causes a substantial 
increase in energy expenditure’.14 It is important to point 
out that ‘physical activity’ and ‘exercise’ are not similar. PA 
can be seen as an overarching term that includes exercise 
as well as other activities that involve bodily movement 
and are done as part of playing, working, active transpor-
tation, house chores and recreational activities. Exercise, 
however, is a subcategory of PA. It is planned, structured, 
repetitive and purposeful to improve or maintain one or 
more components of physical fitness (cardiorespiratory 
fitness, muscular strength, muscular endurance, flexibility 
and body composition).15 These components represent 
important outcomes in cancer survivors that may mediate 
the influence of exercise on other outcomes.14
Psychosocial interventions are another important focus 
in rehabilitation. These sort of interventions aim to help 
patients cope with negative side effects of cancer diag-
nosis and treatment.16 Based on a framework proposed 
by Buffart et al, there are five categories of interventions: 
patient education, social support, coping skills training, 
psychotherapy and spiritual/existential therapy.17
How the intervention might work
In order to explain how cancer rehabilitation interven-
tions might work, the revised Wilson and Cleary Model for 
HRQoL will be used as a conceptual framework.18 This is 
useful to explain the pathways between different patient 
outcomes.19 The model proposes five types of patient 
outcome measurements (biological function, symptoms, 
functional status, health perception and overall QOL), 
which have a causal relationship.18 20 These five patient 
outcome measurements can be influenced by individual 
and environment characteristics.
In case of BC, morbidity associated with the disease and 
its treatment can lead to complications related to urinary 
diversion, urinary incontinence or constipation, sexual 
dysfunction,21 fatigue and psychological distress.22 This 
can potentially lead to a loss of physical, social, psycho-
logical and role function, which affects activities in daily 
life. As a consequence, the general health perceptions of 
the patient can be damaged, which can finally lead to an 
overall impaired QOL. All of these outcomes can be influ-
enced by environment and individual characteristics.
Offering cancer rehabilitation can be seen as a phys-
ical environment characteristic. Since it has been proven 
in other cancer populations that cancer rehabilitation 
interventions have a positive influence on, for example, 
physical fitness,23 muscle capacity,24 fatigue and emotional 
distress,25 we can conclude, according to the revised 
Wilson and Cleary Model for HRQoL, that cancer reha-
bilitation interventions can have a positive influence on 
other patient outcomes such as HRQoL.18
Individual characteristics, such as advanced age and the 
associated increased risk of comorbidities, are important 
factors to take into account in patients with BC. These 
characteristics are associated with poorer health26 such 
as functional and psychosocial declines.27 Although this 
supports the need for cancer rehabilitation, the older age 
of patients with BC creates challenges in recommending 
rehabilitation interventions. Potential difficulties are 
the lack of social support in older patients and the need 
for extra time and resources to enrol these patients.28 
Additionally, the high prevalence of urinary complica-
tions and problems with body image in patients with BC 
can act as potential barriers to participate in exercise 
interventions.26 According to Karvinen et al, exercise 
interventions for BC survivors should focus on offering 
enjoyable activities, education on the benefits of regular 
exercise, improving activity levels in important others and 
targeting perceived barriers. They also note that adjuvant 
therapy, age and invasiveness of the tumour may affect 
exercise participation.26 Furthermore, BC survivors seem 
to be most interested in walking and home-based, indi-
vidual exercises that are not supervised.29
Why it is important to do this review
With an increasing number of cancer survivors, cancer 
rehabilitation will become imperative in cancer survivor-
ship. In order to develop evidence-based rehabilitation 
programmes for patients with BC who received a cura-
tive treatment, it is essential to have a global picture 
of effective rehabilitation interventions. Therefore, a 
systematic review assessing the effects of exercise-based 
and psychosocial rehabilitation interventions inpatients 
with BC is needed. A previous systematic review assessed 
the associations of lifestyle factors (diet, smoking and 
PA) on HRQoL in BC survivors. Findings of this review 
concluded that there was limited evidence to support 
a positive association between HRQoL and PA in BC 
survivors.30 Our review differs with previous review in 
several aspects. First, we want to identify well-defined 
interventions that are effective. In previous review, they 
evaluated the PA pattern of the patient, which is not 
the same as an exercise intervention. Furthermore, this 
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review will assess multiple other outcomes in addition to 
HRQoL (explained below). Additionally, to our knowl-
edge, there is no systematic review that has summarised 
the evidence of psychosocial rehabilitation interventions 
in MIBC survivors in a systematic manner.
So far, no specific guidelines exist for exercise-based 
and/or psychosocial rehabilitation interventions for 
MIBC survivors. This review could give guidance to the 
development of specific evidence-based guidelines. 
Although this review focuses only on the exercise and 
psychosocial part of rehabilitation, it is important to note 
that rehabilitation of patients with cancer requires also 
other interventions such as diet counselling, smoking 
cessation and so on.12
It should also be noticed that providing cancer rehabil-
itation is an often-neglected facet of cancer care in terms 
of health policy and infrastructure.31 Frequently reported 
barriers to rehabilitation interventions are the lack of 
expertise, inappropriate referrals by physicians, funding 
issues24 31 and availability of rehabilitation resources.32 
The results of this review may increase the awareness of 
physicians and funders of the importance of cancer reha-
bilitation.
aims and oBjecTives
Primary objective
Assessing the effects of rehabilitation interventions 
(exercise-based and psychosocial interventions) on 
patient-reported outcomes (PROs) (eg, QOL, fatigue and 
pain) and physical fitness in MIBC survivors.
secondary objective
Identifying significant moderators of the intervention 
effects.
meTHods
The overall approach of this review is consistent with the 
methodology described in the Cochrane Handbook for 
Systematic Reviews of Interventions33 and is described 
below. Reports of current systematic review protocol 
adhere to the Preferred Items for Systematic Reviews 
and Meta-Analysis Protocol (PRISMA-P) checklist.34 The 
systematic review itself will adhere to the PRISMA.35
criteria for considering studies for this review
Types of studies
Because of the anticipated low amount of randomised 
controlled trials (RCTs), RCTs and non-randomised 
studies (NRS) (ie, cohort studies, case–control studies, 
cross-sectional studies and quasi-randomised controlled 
clinical trials) will be considered as appropriate study 
designs. Results from RCTs and NRS will be presented 
separately.
Types of participants
The population of interest will be adults (≥18 years of 
age) with medically confirmed diagnosis of localised 
MIBC or high-risk NMIBC for whom a radical cystec-
tomy is indicated. Studies with a majority of patients with 
metastasised BC will be excluded. Demographic factors 
are no exclusion criteria except for age (<18 years of age). 
Studies involving participants with a range of cancers or 
other diagnoses that report results specifically for patients 
with MIBC will be included. Studies involving participants 
with urological cancers where data are not provided sepa-
rately for patients with MIBC will be excluded.
Types of interventions
Exercise-based rehabilitation interventions considered 
for this review will be aerobic or endurance activities, 
strength or resistance training, balance exercises, flex-
ibility exercises (with inclusion of yoga and Pilates), 
exercises specific to address sexual functioning and pelvic 
floor exercises in case of bladder preserving strategies or 
bladder reconstruction after radical cystectomy. Gener-
alised advice to engage in regular PA activity will not be 
considered as an exercise-based rehabilitation interven-
tion. In this review, the focus will be placed on exercise in 
a planned, structured, repetitive and purposeful rehabili-
tation intervention. PA as part of playing, working, active 
transportation, house chores or recreational activities will 
not be included.
Psychosocial rehabilitation interventions eligible for 
inclusion will be based on the framework proposed 
by Buffart et al: patient education (eg, stoma manage-
ment, generalised advice to engage in PA activity), social 
support, coping skills training, psychotherapy and spiri-
tual/existential therapy.17 Complementary medicine and 
therapies will not be included in this review.
Both intervention types can either be individual or in 
group, hospital based or home based (with follow-up by 
a professional), supervised by a physiotherapist or not 
and can be given before, during and/or after treatment. 
No limits will be placed on the timing, frequency, inten-
sity and duration of rehabilitation interventions. The 
interventions will be compared with an inactive control 
intervention (eg, no treatment, standard care or a waiting 
list control).
Types of outcome measures
For both primary and secondary outcome measures, 
there will be no exclusion based on length of follow-up.
Primary outcomes
1. PROs including overall HRQoL, specific HRQoL 
domains including symptoms such as fatigue, 
pain, urinary incontinence, sexual dysfunction, 
gastrointestinal dysfunction and psychological 
factors such as anxiety, depression, stress and self-
esteem. Due to the wide range of questionnaires 
used for PROs and the non-consensus of using 
one standardised questionnaire, only studies using 
the standardised and validated measurement 
instruments for PRO, found in Table 1,36–48 will 
be included. All studies using other measurement 
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instruments will be excluded, unless proof of their 
validation can be found in literature.
2. Physical fitness assessed by VO2 peak, VO2 max, 
6 or 12 min walk test, 400 m walk test, handgrip 
strength tests, sit and reach tests or other proven to 
be validated instruments.
Secondary outcomes
1. Cancer recurrence, cancer-specific survival, 
progression-free survival, overall survival, mortality, 
years of life lost or 5-year survival.
2. Body composition assessed by height, weight, 
body mass index, muscle capacity, fat mass, lean 
body mass, thickness of skin folds, body fat, 
arm circumference, waist circumference, hip 
circumference or waist–hip ratio.
3. Bone mineral density or fracture risk assessed by 
fracture risk assessment tool.49
4. Karnofsky performance score.50
search methods for identification of studies
Electronic searches
The following electronic databases will be searched from 
inception until the search date: the Cochrane Central 
Register of Controlled Trials (CENTRAL), MEDLINE 
(using the PubMed interface), Embase (using the  embase. 
com interface), Web of Science and the Physiotherapy 
Evidence Database (PEDro). The search strategies will 
be evaluated using the Peer Review of Electronic Search 
Strategies (PRESS) checklist51 and will be monitored and 
peer reviewed by an information specialist (NSP). The 
search strategies are presented in  online supplementary 
file 1.
Searching other resources
The cited and citing references of the included studies 
will be checked via Web of Science.
data collection and analysis
Selection of studies
All references found through the search process will be 
downloaded in a database created by reference manage-
ment software (Endnote). After removing duplicates 
in Endnote, all references will be imported into Covi-
dence for screening purposes. Obviously irrelevant 
studies, based on title and abstract, will independently 
be excluded by two review authors (ER and VF). After 
screening the titles and abstracts, two review authors (ER 
and VF) will independently assess full-text reports for 
eligibility. Discrepancies will be discussed with a third 
review author (NS). Reasons for exclusion of full-texts will 
be documented. Studies will be excluded if no full-text is 
available. Abstracts in any other language than English 
will be excluded. There will be no language restric-
tion for full texts, and translations will be carried out if 
necessary. If studies have multiple publications with the 
same outcome(s) reported, manuscripts with the longest 
follow-up will be selected for inclusion. Older publications 
Table 1 Standardised and validated measurement instruments for the included patient-reported outcomes
Patient-reported outcome Validated measurement instrument
HRQoL EQ-5D visual analogue scale, SF-36, Ferrans and Powers QLI, WHO QOL, SF-12, Padilla 
QLI, SF-20 and Satisfaction With Life Scale
Cancer-specific QOL FACT-G, EORTC QLQ-C30, FLIC, Selby’s QLI, Cleary’s QLI and CARES-SF
Bladder cancer-specific QOL EORTC QLQ-BLM30, BCI and FACT-BI
Sexual function IIEF-5 and FSFI
Gastrointestinal function GIQLI
Urinary incontinence BCI supplement, ICIQ-UI SF, IPSS
Psychological factors
Depression
Anxiety
Stress
Self-esteem
BSI-18, BDI,ISR-depression scale
STAI anxiety scales, numeric rating scales or visual analogue scale
Perceived Stress Scale
Rosenberg self-esteem scale
Abbreviations: HRQoL, Health-Related Quality of Life; QOL, Quality of Life; EQ-5D, EuroQol-5D; SF-36, 36-item short form 
health survey; QLI , Quality of Life index; WHO, World Health Organization; SF-12, 12-item short form health survey; SF-
20 ,20-item short form health survey; FACT-G ,functional assessment of cancer therapy - general; EORTC , The European 
Organization for Research and Treatment of Cancer; QLQ-C30, Quality of Life Questionnaire-core 30; FLIC , functional 
living index - cancer; CARES-SF, Cancer Rehabilitation Evaluation System short form; QLQ-BLM30,30-item Quality of Life 
Questionnaire for patients with muscle-invasive bladder cancer; BCI,bladder cancer index; FACT-Bl , functional assessment 
of cancer therapy questionnaire for patients with bladder cancer; IIEF-5 = the international index of erectile function-5; 
FSFI,female sexual function index; GIQLI, gastrointestinal quality of life index; ICIQ-UI SF, international consultation on 
incontinence questionnaire-urinary incontinence-short form; IPSS, the international prostate symptom score; BSI-18, the brief 
symptom inventory 18 ; BDI = beck depression inventory; ISR , International Classification of Diseases-10 symptom rating; 
STAI ,the state-trait anxiety inventory 
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referred to in included articles will be accessed to clarify 
methods if required.
Data extraction
A modified Effective Practice and Organisation of 
Care (EPOC) data collection form of the Cochrane collab-
oration will be used and pilot tested with at least three 
studies in the review.52 After pilot testing the form, adjust-
ments can be made. Data extraction will be performed 
independently by two review authors (ER and VF). For 
each included study in the review, at least following infor-
mation will be extracted:
 ► General information: date form completed, name 
of person extracting data, report title, report ID, 
authors' names, source, country, contact address, 
language of publication and year of publication.
 ► Population and setting: population description 
(from which study participants are drawn), setting 
(eg, inpatient, outpatient, hospital setting, home 
setting and combination) and inclusion and 
exclusion criteria.
 ► Methods: aim of study, design, unit of allocation, 
start and end date and duration of participation.
 ► Participants: number of participants in intervention 
and control groups, details of clusters if applicable, 
baseline imbalances, participant demographics 
such as sex and age, disease-related characteristics 
such as stage of disease, received treatment(s) and 
comorbidities.
 ► Intervention: type of intervention (exercise based, 
psychosocial or combination), details of intervention 
type (eg, aerobic, pelvic floor exercises, counselling, 
patient education), cointervention(s), type of 
control intervention, frequency, duration and 
providers of the intervention.
 ► Outcomes: outcome name, time points measured 
and reported, outcome definition, person 
measuring/reporting, upper and lower limits of 
scales, unit measurement if relevant, if outcome/
tool is validated, imputation of missing data and 
assumed risk estimate if reported.
 ► Results: outcome, measurement effects (please see 
data analyses below) for intervention and comparison 
group, baseline data, number of missing participants 
and reasons and statistical methods used.
Assessment of risk of bias in included studies
The Cochrane Collaboration’s tool for assessing risk of 
bias will be used for RCTs. Assessment of risk of bias 
in NRS will be done using the Newcastle-Ottawa Scale 
for observational studies. The assessment of risk of bias 
will be done independently by two reviewers (ER and 
NSP). Differences will be discussed and a third reviewer 
(NS) will be consulted when needed. Results will be 
summarised both in a graph and a narrative summary. 
In order to evaluate selective reporting, the reviewers 
will check clinical trial registries or search any proto-
cols of the studies for a priori reported primary and 
secondary outcome measures. The strength of the body 
of evidence will be assessed according to the GRADE 
approach.
Dealing with missing data
If essential data are not available in the publication, we 
will first attempt to contact the study authors. If this is 
not possible, we will try to back-calculate from the data 
presented. If data will be obtained from other study 
authors, this will be reported in the review in a transparent 
manner. This way, we can keep in mind that these missing 
data obtained from study authors were not peer reviewed. 
Studies assessing lifestyle interventions may have issues 
with compliance. Therefore, reasons for missing data 
(eg, dropouts, losses to follow-up and withdrawals) will be 
carefully reported.
Assessment of heterogeneity
First, there will be a critical consideration of the 
heterogeneity between the different interventions and 
outcomes to evaluate whether there is clinical diversity. 
Based on this evaluation, there will be a decision if a 
meta-analysis can be conducted. When there’s no clinical 
heterogeneity, statistical heterogeneity will be quanti-
fied using the I2 statistic. We will consider the statistical 
heterogeneity to be high if I2 >50%. Depending on the 
heterogeneity of the studies and their results, we will 
further decide if a meta-analysis can be conducted. We 
will attempt to explain any observed heterogeneity in 
the review.
Assessment of reporting bias
Funnel plots will be used to assess publication bias when 
10 or more studies are included in a meta-analysis.
Data synthesis
The findings from the included studies will be summarised 
descriptively. For dichotomous outcomes, measurement 
of treatment effect will be reported as risk ratios and 95% 
CIs. For continuous outcomes, we will calculate mean 
differences and 95% CIs when results are reported on 
the same scale (or can be converted to the same scale) or 
standardised mean differences and 95% CIs if results are 
reported on different scales.
There will be an attempt to identify significant moder-
ators, based on the most important demographical and 
clinical characteristics in this population. In order to 
do this, there will be a subgroup analysis for age and 
urinary diversion type. To prevent cointervention bias, 
there will also be a subgroup analysis based on the type 
of intervention (only exercised-based interventions, only 
psychosocial interventions or a combination).
When homogeneity of the studies is sufficient, 
random-effects meta-analysis will be undertaken sepa-
rately for each type of study design. Only studies with low 
risk of bias will be included in meta-analyses. Therefore, 
we will perform sensitivity analyses to investigate how 
conclusions might be affected if studies at high or unclear 
risk of bias were included.
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ethics and dissemination
Ethics approval is not required, as no primary data will be 
collected. Results will be disseminated through a peer-re-
viewed publication.
The scope of this review is broad (ie, different rehabil-
itation interventions and study designs). Although this 
means that heterogeneity might be present between the 
studies, evaluation of different intervention approaches is 
needed to develop optimal rehabilitation or survivorship 
programmes. Caution will be present in the interpretation 
of the results because of the fact that evidence from RCTs 
is higher than evidence from NRS. Therefore, the results 
derived from RCTs will be seen as the primary evidence. 
Results from NRS will be seen as additional evidence to 
support the results from RCTs.
This systematic review has several strengths. First, the 
overall approach of this review is consistent with the 
methodology described in the Cochrane Handbook for 
Systematic Reviews of Interventions. Second, rehabili-
tation interventions are an innovative topic in the field 
of BC so this review ensures an absolute value. A third 
strength is the fact that MIBC is an actual problem 
because of the potentially rising incidence of MIBC due 
to the ageing population.
The results of this systematic review could also have 
potential limitations in terms of biased results due to the 
nature of exercise and psychosocial interventions. It is 
impossible for such interventions to blind participants 
and personnel. Therefore, ‘blinding of participants and 
personnel’ will not be taken into account in the risk of 
bias assessment because of the thought that this will not 
necessarily affect the study quality. However, attrition 
and adherence biases and selective reporting biases are 
other common concerns around high risk of bias that 
would affect the study quality.53 Therefore, it is important 
that the risk of bias assessment will be carried out very 
carefully. Another limitation of this review could be the 
possible paucity of studies meeting the inclusion criteria.
In spite of these anticipated limitations, it is important to 
conduct this review because of the expected implications 
for healthcare, research and survivorship. To date, there 
are no specific guidelines for exercise-based or psychoso-
cial rehabilitation interventions for MIBC survivors. This 
systematic review is expected to provide guidance to the 
development of specific guidelines and evidence-based 
rehabilitation or survivorship programmes for MIBC 
survivors. Development of such programmes could have 
further implications for healthcare if they will be trans-
lated into daily clinical practice.
By identifying those interventions that have a positive 
effect on patient outcomes and which underlying factors 
ensure the success of such rehabilitation interventions, 
new interventions can be developed that can contribute 
to further research. The positive influence of PA on survi-
vorship is already suggested in different tumour types.54 
The results of this systematic review can contribute to 
patient survivorship from the hypothesis that this positive 
association is also applicable in MIBC.
Contributors ER drafted the manuscript and developed the methods and analyses 
strategy. VF coordinated the process. NSP and NS aided in developing the search 
strategy. VF, PO and KD provided uro-oncology-specific expertise. RB and BD gave 
valuable input concerning rehabilitation.
Funding This study is funded by a grant of Kom op tegen Kanker. The granting 
bodies are not involved in data collection or analysis.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement There is no additional unpublished data.
Open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4.0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
RefeRenCeS
 1. Witjes JA, Compérat E, Cowan NC, et al. EAU guidelines 2016: 
muscle invasive and metastatic bladder Cancer. https://uroweborg/
guideline/bladder-cancer-muscle-invasive-and-metastatic/ (accessed 
on 12/10/2016).
 2. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors 
of urothelial bladder Cancer. Eur Urol 2013;63:234–41.
 3. Malats N, Real FX. Epidemiology of bladder cancer. Hematol Oncol 
Clin North Am 2015;29:177–89.
 4. Shahrokh FS, Milowsky M, Droller MJ. Bladder Cancer in the elderly. 
Urologic Oncology 2009;27:653–67.
 5. Stenzl A, Witjes J, Compérat E, et al. Bladder Cancer Muscle-
invasive and metastatic. UPDATE 2012.
 6. van Rhijn BW, Burger M, Lotan Y, et al. Recurrence and progression 
of disease in non-muscle-invasive bladder Cancer: from 
epidemiology to treatment strategy. Eur Urol 2009;56:430–42.
 7. Wright JL, Porter MP. Quality-of-life assessment in patients with 
bladder Cancer. Nat Clin Pract Urol 2007;4:147–54.
 8. Mohamed NE, Gilbert F, Lee CT, et al. Pursuing Quality in the 
application of bladder Cancer quality of Life Research. Bladder 
Cancer 2016;2:139–49.
 9. National Cancer Institute. Division of Cancer control & population 
sciences. 2016 https://cancercontrolcancergov/ocs/statistics/
definitionshtml (accessed on 11/10/2016).
 10. Hojan K. Contemporary rehabilitation at Cancer centres. Journal of 
Medical Science 2016;83:156–60.
 11. Gudbergsson SB, Dahl AA, Loge JH, et al. What is covered by 
"cancer rehabilitation" in PubMed? A review of randomized 
controlled trials 1990-2011. J Rehabil Med 2015;47:97–106.
 12. :87-101.Weis J, Giesler JM. Rehabilitation for cancer patients. 
Psycho-Oncology 2014.
 13. Harrison JD, Young JM, Price MA, et al. What are the unmet 
supportive care needs of people with Cancer? A systematic review. 
Support Care Cancer 2009;17:1117–28.
 14. McGowan EL, Courneya KS. Exercise interventions in supportive 
oncology, 2011.
 15. World Health Organisation. Global Strategy on Diet. Physical Activity 
and Health http://wwwwhoint/dietphysicalactivity/pa/en/ (accessed 
on 11/10/2016).
 16. Parahoo K, McDonough S, McCaughan E, et al. Psychosocial 
interventions for men with prostate Cancer. The Cochrane Library 
2013.
 17. Buffart LM, Kalter J, Chinapaw MJ, et al. Predicting OptimaL cAncer 
RehabIlitation and supportive care (POLARIS): rationale and design 
for meta-analyses of individual patient data of randomized controlled 
trials that evaluate the effect of physical activity and psychosocial 
interventions on health-related quality of life in Cancer survivors. Syst 
Rev 2013;2:1.
 18. Ferrans CE, Zerwic JJ, Wilbur JE, et al. Conceptual model of health-
related quality of life. J Nurs Scholarsh 2005;37:336–42.
 19. Saban KL, Penckofer SM, Androwich I, et al. Health-related quality 
of life of patients following selected types of lumbar spinal surgery: a 
pilot study. Health Qual Life Outcomes 2007;5:71.
 20. Hacker E. Exercise and quality of life: strengthening the connections. 
Clin J Oncol Nurs 2009;13:31–9.
group.bmj.com on June 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 7Rammant E, et al. BMJ Open 2017;7:e016054. doi:10.1136/bmjopen-2017-016054
Open Access
 21. Jensen BT, Jensen JB, Laustsen S, et al. Multidisciplinary 
rehabilitation can impact on health-related quality of life outcome in 
radical cystectomy: secondary reported outcome of a randomized 
controlled trial. J Multidiscip Healthc 2014;7:301–11.
 22. Palapattu GS, Haisfield-Wolfe ME, Walker JM, et al. Assessment of 
perioperative psychological distress in patients undergoing radical 
cystectomy for bladder Cancer. J Urol 2004;172:1814–7.
 23. Buffart LM, Kalter J, Sweegers MG, et al. Effects and moderators 
of exercise on quality of life and physical function in patients with 
Cancer: an individual patient data meta-analysis of 34 RCTs. Cancer 
Treat Rev 2017;52:91–104.
 24. Alfano CM, Ganz PA, Rowland JH, et al. Cancer survivorship 
and Cancer rehabilitation: revitalizing the link. J Clin Oncol 
2012;30:904–6.
 25. Andersen BL. Biobehavioral outcomes following psychological 
interventions for Cancer patients. J Consult Clin Psychol 
2002;70:590–610.
 26. Karvinen KH, Courneya KS, Plotnikoff RC, et al. A prospective study 
of the determinants of exercise in bladder Cancer survivors using the 
Theory of Planned Behavior. Support Care Cancer 2009;17:171–9.
 27. Brown JC, Winters-Stone K, Lee A, et al. Cancer, physical activity, 
and exercise. Compr Physiol 2012;2:2775-809.
 28. Grabowski JP, Pintus Dla, Ramesh HSJ, et al. The Challenges of 
Treating Cancer in Older Patients – How Effective Are Clinical Trials in 
Developing Unique Treatments? Eur Oncol Haematol 2008;04:94–6.
 29. Karvinen KH, Courneya KS, Venner P, et al. Exercise programming 
and counseling preferences in bladder Cancer survivors: a 
population-based study. J Cancer Surviv 2007;1:27–34.
 30. Gopalakrishna A, Longo TA, Fantony JJ, et al. Lifestyle factors and 
health-related quality of life in bladder Cancer survivors: a systematic 
review. J Cancer Surviv 2016;10:874–82.
 31. Pearson EJM, Twigg VJ. A framework for rehabilitation for Cancer 
survivors. Eur J Cancer Care 2013;22:701–8.
 32. Bultijnck R, Surcel C, Ploussard G, et al. Practice patterns compared 
with Evidence-based strategies for the management of androgen 
deprivation Therapy–Induced Side Effects in Prostate Cancer 
Patients: Results of a European Web-based Survey. European 
Urology Focus 2016;2:514–21.
 33. Higgins JPT, ed. Cochrane Handbook for Systematic Reviews of 
Interventions Version 5.1.0 [updated March 2011: The Cochrane 
Collaboration, 2011. Available from. www. handbook. cochrane. org .
 34. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for 
systematic review and meta-analysis protocols (PRISMA-P) 2015: 
elaboration and explanation. BMJ 2015;349:g7647.
 35. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for 
systematic reviews and meta-analyses: the PRISMA statement. BMJ 
2009;339:b2535.
 36. Urologic Oncology: Seminars and Original Investigations. Measuring 
health-related quality of life in men with prostate Cancer: a 
systematic review of the most used questionnaires and their validity. 
Elsevier, 2015.
 37. Danna BJ, Metcalfe MJ, Wood EL, et al. Assessing Symptom Burden 
in Bladder Cancer: an overview of bladder Cancer specific Health-
Related Quality of Life Instruments. Bladder Cancer 2016;2:329–40.
 38. Vodermaier A, Linden W, Siu C. Screening for emotional distress in 
Cancer patients: a systematic review of assessment instruments. J 
Natl Cancer Inst 2009;101:1464–88.
 39. Brandt WA, Loew T, von Heymann F, et al. How does the ICD-10 
symptom rating (ISR) with four items assess depression compared to 
the BDI-II? A validation study. J Affect Disord 2015;173:143–5.
 40. Hornblow AR, Kidson MA. The visual analogue scale for anxiety: a 
validation study. Aust N Z J Psychiatry 1976;10:339–41.
 41. Araujo IB, Castelani A, Soler T, et al. Stress assessment in the elderly 
by the perceived stress Scale (PSS). International Psychogeriatrics 
2015;27:S119–S19.
 42. Li CC, Chen ML, Chang TC, et al. Social support buffers the effect of 
self-esteem on quality of life of early-stage cervical Cancer survivors 
in Taiwan. Eur J Oncol Nurs 2015;19:486–94.
 43. Gilbert SM, Dunn RL, Hollenbeck BK, et al. Development and 
validation of the bladder Cancer index: a comprehensive, disease 
specific measure of health related quality of life in patients with 
localized bladder Cancer. J Urol 2010;183:1764–70.
 44. Dargis L, Trudel G, Cadieux J, et al. Validation of the International 
Index of Erectile function (IIEF) and presentation of norms in older 
men. Sexologies 2013;22:e20–e26.
 45. Baser RE, Li Y, Carter J. Psychometric validation of the female sexual 
function index (FSFI) in Cancer survivors. Cancer 2012;118:4606–18.
 46. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal 
Quality of Life Index: development, validation and application of a 
new instrument. Br J Surg 1995;82:216–22.
 47. Hajebrahimi S, Nourizadeh D, Hamedani R, et al. Validity and 
reliability of the International Consultation on Incontinence 
Questionnaire-Urinary Incontinence Short form and its correlation 
with urodynamic findings. Urol J 2012;9:685.
 48. Gray M. Psychometric evaluation of the international prostate 
symptom score. Urol Nurs 1998;18:175.
 49. Watts NB, Lewiecki EM, Miller PD, et al. National Osteoporosis 
Foundation 2008 Clinician's Guide to Prevention and Treatment 
of Osteoporosis and the World Health Organization Fracture Risk 
Assessment Tool (FRAX): what they mean to the bone densitometrist 
and bone technologist. J Clin Densitom 2008;11:473–7.
 50. Mor V, Laliberte L, Morris JN, et al. The Karnofsky Performance 
Status Scale. an examination of its reliability and validity in a 
research setting. Cancer 1984;53:2002–7.
 51. McGowan J, Sampson M, Salzwedel DM, et al. PRESS Peer Review 
of Electronic search strategies: 2015 Guideline Statement. J Clin 
Epidemiol 2016;75:40–6.
 52. Effective Practice and Organisation of Care (EPOC). EPOC 
Resources for review authors. Oslo: norwegian knowledge Centre 
for the Health Services; 2015. secondary effective practice and 
Organisation of Care (EPOC). EPOC Resources for review authors. 
Oslo: norwegian knowledge Centre for the Health Services;. 2015 
http:// epoc. cochrane. org/ epoc- specific- resources- review- authors .
 53. Bourke L, Smith D, Steed L, et al. Exercise for men with prostate 
Cancer: a systematic review and Meta-analysis. Eur Urol 
2016;69:693–703.
 54. Ammitzbøll G, Søgaard K, Karlsen RV, et al. Physical activity and 
survival in breast Cancer. Eur J Cancer 2016;66:67–74.
group.bmj.com on June 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
bladder cancer: a systematic review protocol
fitness in survivors of muscle invasive
patient-reported outcomes and physical 
Rehabilitation interventions to improve
Valérie Fonteyne
Pauwels, Benedicte Deforche, Ronny Pieters, Karel Decaestecker and 
Elke Rammant, Renée Bultijnck, Nora Sundahl, Piet Ost, Nele S
doi: 10.1136/bmjopen-2017-016054
2017 7: BMJ Open 
 http://bmjopen.bmj.com/content/7/5/e016054
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/7/5/e016054
This article cites 44 articles, 4 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (70)Urology
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on June 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
